Skip to main content

Illumina, maker of DNA sequencing machines, had a small round of layoffs in September

In its last earnings call, Illumina noted that it was impacted by weaknesses in the direct-to-consumer market, as sales of genetic tests from companies like 23andMe and Ancestry were down.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.